| Name | Title | Contact Details |
|---|
FPV racing drones. The top pilots in the world. Epic courses. Follow the DRL 2018 Season.
Freespace can automate workplace processes, validate real estate decisions, and enrich the office culture and employee experiences.
Manufacturing planning, scheduling, sequencing simplified. Complete modelling and optimization technology provides validated customer benefits. Installed on-premise or cloud access.
11:11 is invested in creating a new model delivering the power of “Everything Connected” for its customers and partners. Fully integrated, fully automated. All services, all activities, all data, all performance, powered on a single platform.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.